Christina Johnson to Receptors, Tumor Necrosis Factor
This is a "connection" page, showing publications Christina Johnson has written about Receptors, Tumor Necrosis Factor.
Connection Strength
0.138
-
An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells. Cancer Biol Ther. 2003 May-Jun; 2(3):283-90.
Score: 0.109
-
Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Cancer Gene Ther. 2003 Nov; 10(11):814-22.
Score: 0.028